MAGOH Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB300-938
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Bovine (100%), Canine (100%), Mouse (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-SLIGLHFKIKPI corresponding to C-Terminus according to NP_002361.1.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for MAGOH Antibody
Western Blot: MAGOH Antibody [NB300-938]
Western Blot: MAGOH Antibody [NB300-938] - (1ug/ml) staining of nuclear HeLa lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for MAGOH Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:2000
Western Blot
1 - 3 ug/ml
Application Notes
WB: Approx. 17 kDa band observed in HeLa nuclear lysates (calculated MW of 17.2 kDa band according to NP_002361.1). Data obtained from a previous batch (different goat).
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: MAGOH
Alternate Names
MAGOHAMAGOH1, mago-nashi (Drosophila) homolog, proliferation-associated, mago-nashi homolog, proliferation-associated (Drosophila), protein mago nashi homolog
Gene Symbol
MAGOH
UniProt
Additional MAGOH Products
Product Documents for MAGOH Antibody
Product Specific Notices for MAGOH Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...